Effects of allopurinol on ischemia and reperfusion in rabbit livers

Transplant Proc. 2009 Apr;41(3):820-3. doi: 10.1016/j.transproceed.2009.02.051.

Abstract

In this work, we evaluated the effects of allopurinol (ALO), an inhibitor of xanthine oxidase (XO), on hepatic lesions caused by ischemia/reperfusion (I/R) in the rabbit liver. Rabbits were pretreated with ALO (10 mg/kg IV) or saline solution 0.9% before the hepatic I/R procedure. The effects of ALO on hepatic injury were evaluated before and after I/R. A standard, warm hepatic I/R procedure caused profound acute liver injury, as indicated by elevated serum aspartate aminotransferase, alanine aminotransferase, and lactic dehydrogenase levels, as well as a high apoptotic cell count. All of these changes were reversed by the administration of ALO before the hepatic I/R procedure. In conclusion, ALO exerted protective effects on hepatic I/R lesions. This protective effect of ALO was probably associated with blocking the generation of superoxide anions during the hepatic I/R procedure by inhibiting XO activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / blood
  • Alanine Transaminase / drug effects
  • Allopurinol / therapeutic use*
  • Animals
  • Aspartate Aminotransferases / blood
  • Aspartate Aminotransferases / drug effects
  • Enzyme Inhibitors / therapeutic use
  • L-Lactate Dehydrogenase / blood
  • L-Lactate Dehydrogenase / drug effects
  • Liver Diseases / prevention & control*
  • Male
  • Rabbits
  • Reperfusion Injury / prevention & control*
  • Xanthine Oxidase / antagonists & inhibitors

Substances

  • Enzyme Inhibitors
  • Allopurinol
  • L-Lactate Dehydrogenase
  • Xanthine Oxidase
  • Aspartate Aminotransferases
  • Alanine Transaminase